Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Sequential antibacterial therapy cost saving

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Sequential antibacterial therapy cost saving. Pharmacoecon. Outcomes News 175, 10 (1998). https://doi.org/10.1007/BF03277709

    Download citation

    Keywords

    • Cost Saving
    • Ofloxacin
    • Cost Analysis
    • Waste Disposal
    • Antimicrobial Therapy